Cyclin-dependent kinase inhibitors move into Phase III

被引：60
|
作者：
Guha, Malini
机构：
来源：
NATURE REVIEWS DRUG DISCOVERY | 2012年 / 11卷 / 12期
关键词：
D O I：
10.1038/nrd3908
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
After more than a decade of clinical development for cancer and numerous failures, Phase III trials of cyclin-dependent kinase inhibitors are beginning.
引用
收藏
页码：892 / 894
页数：3
相关论文
共 50 条
  • [41] Molecular analysis of cyclin-dependent kinase inhibitors in human leukemias
    Hayette, S
    Thomas, X
    Bertrand, Y
    Tigaud, I
    Callanan, M
    Thiebaut, A
    Charrin, C
    Archimbaud, E
    Magaud, JP
    Rimokh, R
    LEUKEMIA, 1997, 11 (10) : 1696 - 1699
  • [42] Molecular models of cyclin-dependent kinase 1 complexed with inhibitors
    Canduri, F
    Uchoa, HB
    de Azevedo, WF
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 324 (02) : 661 - 666
  • [43] Clinical progress of selective cyclin-dependent kinase (CDK) inhibitors
    Misra, RN
    DRUGS OF THE FUTURE, 2006, 31 (01) : 43 - 52
  • [44] Mechanisms of resistance to cyclin-dependent kinase 4/6 inhibitors
    Georgia Gomatou
    Ioannis Trontzas
    Stephanie Ioannou
    Maria Drizou
    Nikolaos Syrigos
    Elias Kotteas
    Molecular Biology Reports, 2021, 48 : 915 - 925
  • [45] Genes coding for cyclin-dependent kinase inhibitors are fragile in Xenopus
    Tanaka, Toshiaki
    Ochi, Haruki
    Takahashi, Shuji
    Ueno, Naoto
    Taira, Masanori
    DEVELOPMENTAL BIOLOGY, 2017, 426 (02) : 291 - 300
  • [46] Cyclin-Dependent Kinase 2 Inhibitors in Cancer Therapy: An Update
    Tadesse, Solomon
    Caldon, Elizabeth C.
    Tilley, Wayne
    Wang, Shudong
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (09) : 4233 - 4251
  • [47] Identification of highly selective inhibitors of cyclin-dependent kinase 12
    Choidas, Axel
    Schultz-Fademrecht, Carsten
    Degeenhardt, Carsten
    Habenberger, Peter
    Koch, Uwe
    Eickhoff, Jan E.
    Greifenberg, Ann Kathrin
    Nussbaumer, Peter
    Geyer, Matthias
    Klebl, Bert M.
    CANCER RESEARCH, 2016, 76
  • [48] Cyclin-dependent kinase inhibitors for the treatment of chronic lymphocytic leukemia
    Blachly, James S.
    Byrd, John C.
    Grever, Michael
    SEMINARS IN ONCOLOGY, 2016, 43 (02) : 265 - 273
  • [49] Structural Basis for Interaction of Inhibitors with Cyclin-Dependent Kinase 2
    Canduri, Fernanda
    de Azevedo, Walter Filgueira, Jr.
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2005, 1 (01) : 53 - 64
  • [50] Mechanisms of resistance to cyclin-dependent kinase 4/6 inhibitors
    Gomatou, Georgia
    Trontzas, Ioannis
    Ioannou, Stephanie
    Drizou, Maria
    Syrigos, Nikolaos
    Kotteas, Elias
    MOLECULAR BIOLOGY REPORTS, 2021, 48 (01) : 915 - 925
12345